PCSK9-IN-20
PCSK9-IN-20 (Compound 3i) is a PCSK9 inhibitor with an IC50 of 3.96 µM. PCSK9-IN-20 decreases PCSK9 and increases LDLR protein expression in vitro[1].
Product Specifications
CAS Number
2929219-77-0
UNSPSC
12352005
Target
PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/pcsk9-in-20.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(C(NC2=NC3=CC=C(CN4CCN(C(OC(C)(C)C)=O)CC4)C=C3S2)=O)C=C1)(NCCC#N)=O
Molecular Formula
C27H32N6O5S2
Molecular Weight
584.71
References & Citations
[1]Zhixin Ma, et al. Identification of benzothiazoles as novel PCSK9 inhibitors. Bioorg Med Chem Lett. 2023 Nov 6:129542.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RR211831L3V 200 µL
Kat5 (NM_001005872) Rat Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
LV678533 1.0 µg DNA
GNAI3 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details